CORNERSTONE THERAPEUTICS
Cornerstone Therapeutics Inc. (NASDAQ: CRTX), headquartered in Cary, N.C., is a specialty pharmaceutical company focused on developing, acquiring, and commercializing products for the respiratory, hospital and related specialty markets. Key elements of the Company's strategy are to focus on identifying therapeutic niches within respiratory, hospital and related specialty markets to leverage existing business and create new opportunities; promote the Company's current products to high prescribing... physicians through the Company's respiratory sales force and to hospital-based healthcare professionals through the Company's hospital sales force; license or acquire rights to existing patent- or trade secret-protected, branded products, which can be promoted through the same channels to generate on-going high-value earnings streams; advance the Company's development projects and further build a robust pipeline; and generate revenues by marketing approved generic products through the Company's wholly owned subsidiary, Aristos Pharmaceuticals, Inc.
CORNERSTONE THERAPEUTICS
Industry:
Biotechnology Health Care Therapeutics
Founded:
2000-01-01
Address:
Cary, North Carolina, United States
Country:
United States
Website Url:
http://www.crtx.com
Total Employee:
51+
Status:
Active
Contact:
9196786537
Email Addresses:
[email protected]
Total Funding:
30 M USD
Technology used in webpage:
SPF Microsoft Azure DNS Mimecast Level 3 Communications Symantec.cloud EasyDNS EsayDNS Hosted
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Regulus Therapeutics
Regulus Therapeutics is a clinical stage biopharmaceutical company focused on the development and discovery of microRNA therapeutics.
Vigeo Therapeutics
Vigeo Therapeutics is a biopharmaceutical company developing novel therapeutic agents intended to treat advanced malignant tumors.
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2012-05-15 | EKR Therapeutics | EKR Therapeutics acquired by Cornerstone Therapeutics | 150 M USD |
| 2012-01-04 | Cardiokine | Cardiokine acquired by Cornerstone Therapeutics | N/A |
| 2008-05-02 | Critical Therapeutics,Inc. | Critical Therapeutics,Inc. acquired by Cornerstone Therapeutics | N/A |
Investors List
Chiesi Pharmaceuticals
Chiesi Pharmaceuticals investment in Post-IPO Debt - Cornerstone Therapeutics
Official Site Inspections
http://www.crtx.com
- Host name: url-fwd.easydns.com
- IP address: 185.169.253.175
- Location: Germany
- Latitude: 51.2993
- Longitude: 9.491
- Timezone: Europe/Berlin
